Similar articles

• Molecular characteristics therapy in AML.

  Radich GP. Radich GP. Clin Adv Hematol Oncol. 2009 Jun;7(6):11-4. Clin Adv Hematol Oncol. 2009. PMID: 19645131 Review. No abstract available.
• Incorporating novel treatment strategies into conventional therapy.

  Estey EH. Estey EH. Clin Adv Hematol Oncol. 2009 Jun;7(6):4-7. Clin Adv Hematol Oncol. 2009. PMID: 19645129 Review. No abstract available.
• Strategies in the treatment of acute myeloid leukemia.

  Lowenberg B. Lowenberg B. Haematologica. 2004 Sep;89(9):1029-32. Haematologica. 2004. PMID: 15377460 No abstract available.
• Intensified induction therapy for children with AML.

  Woods WG. Woods WG. Ann Hematol. 2004;83 Suppl 1:S119-20. doi: 10.1007/s00277-004-0850-2. Ann Hematol. 2004. PMID: 15124701 No abstract available.
• Optimal post-remission therapy for flow-cytometry minimal residual disease positive adult patients with acute myeloid leukemia.

  Buccisano F, Maurillo L, Del Poeta G, Gattei V, Amadori S, Venditti A. Buccisano F, et al. Haematologica. 2006 Dec;91(12 Suppl):ELT14; author reply ELT15. Haematologica. 2006. PMID: 17194674 No abstract available.